Intracranial Pressure Monitoring Devices Market Size, Share & Trends Analysis Report By Technique (Invasive, Non-invasive), By Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage, Others), By End-Use (Emergency Room, Intensive Care Units, Operating Rooms) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Intracranial Pressure Monitoring Devices Market Size

The global intracranial pressure monitoring devices market size was valued at USD 1.61 billion in 2022 and is projected to reach USD 2.56 billion by 2031, growing at a CAGR of 5.3% during the forecast period (2023–2031).

Increasing awareness about deformity correction surgeries and the growing incidence of facial fractures and injuries are leading to an increase in minimally invasive surgeries, which is further expected to boost the demand for ICP monitoring devices.

Intracranial pressure (ICP) monitoring devices are critical in managing various neurological conditions by measuring and monitoring the pressure inside the skull. These devices assess the pressure exerted by cerebrospinal fluid (CSF) on the brain tissue and blood vessels within the cranial cavity. By continuously monitoring intracranial pressure, healthcare professionals can gather valuable information about the brain's physiological status and detect any abnormalities or changes in pressure that may require intervention. There are two main types of intracranial pressure monitoring devices: invasive and non-invasive. Invasive devices involve the placement of a catheter or sensor directly into the intracranial space to obtain accurate and real-time pressure measurements. This method typically requires drilling a small hole in the skull to insert the catheter or sensor. Examples of invasive devices include intraventricular catheters and epidural and subdural sensors. These devices provide precise and reliable measurements, making them ideal for patients requiring close monitoring or those with severe neurological conditions.

On the other hand, non-invasive intracranial pressure monitoring devices provide an indirect assessment of intracranial pressure without the need for invasive procedures. These devices utilize external measurements and techniques to estimate intracranial pressure. Non-invasive methods are generally safer and more comfortable for patients, making them suitable for long-term monitoring or cases where invasive procedures are not feasible. Some examples of non-invasive techniques include ultrasound imaging, transcranial Doppler, and optic nerve sheath diameter measurement. Although non-invasive devices may not offer the same level of accuracy as invasive methods, they still provide valuable information. They can help healthcare professionals make informed decisions regarding patient care.

Intracranial Pressure Monitoring Devices Market Growth Factors

Rising demand for minimally invasive surgeries

Advanced Intracranial Pressure (ICP) monitoring devices have been designed using noninvasive mechanisms. HS-1000M Monitor by HeadSense Medical, Ltd. uses acoustic sound to measure the ICP. Various benefits of these procedures, such as smaller incisions, faster recovery time, lower trauma, and low risk of complications due to the surgery, contribute to market growth. Increasing awareness about deformity correction surgeries and the growing incidence of facial fractures and injuries are leading to an increase in minimally invasive surgeries, which is further expected to boost the demand for ICP monitoring devices.

Organizations such as the American Society of Craniofacial Surgery and the International Society of Craniofacial Surgery are conducting research programs to increase awareness about craniomaxillofacial surgeries, which may propel market growth over the forecast period.

Launch of new technologies

The development of advanced devices such as surgical robots, surgical microscopes, ophthalmic surgical devices, and neurosurgery devices has reduced direct human interference in surgical procedures. Moreover, increasing demand for minimally invasive surgeries has bolstered market growth. These devices ' periodic maintenance and quality checks are required to maintain precision and accuracy. Medical robotics has witnessed a paradigm shift over the years due to technological advancements in 3D imaging.

Recent innovations include high-definition small cameras, data recorders, data analysis systems, motion sensors, remote guidance systems, catheters, and robotic instruments. The scope of technological advancements is to find new applications for existing platforms and create disruptive technologies that drive the market. There is a growing trend in the robotics business of companies working together on technology platforms with third-party vendors to develop new applications.

Market Restraining Factors

Lack of skilled professionals

Traditional intracranial devices are invasive and require a high level of operational skills. The lack of skilled workers will likely slow the demand for these devices. In places like China and India that are still growing, the shortage of neurosurgeons has been a concern for many years. The rise in neurosurgeons is not proportional to the developing healthcare infrastructure in these countries. The public sector is especially struggling to hire neurosurgeons permanently. This unavailability of professionals is expected to negatively affect the market over the next few years. Despite the high focus on R&D for advanced noninvasive ICP devices, longer approval procedures and slow market penetration are anticipated to hinder market growth.

Market Opportunities

Growing number of applications provide a huge scope for the development of electrodes

The global intracranial pressure monitoring devices market presents significant opportunities driven by the growing number of applications that provide a huge scope for the development of electrodes. Intracranial pressure monitoring is widely used in various medical fields, including neurology, neurosurgery, critical care, and trauma management. Traditionally, intracranial pressure has been monitored using invasive techniques, such as intraventricular or intraparenchymal catheters. However, technological advancements have developed novel electrodes and sensors that improve accuracy, reliability, and patient comfort.

One of the key opportunities in the market is the development of advanced electrodes for intracranial pressure monitoring. Electrodes are an integral part of the monitoring system, and their design and functionality play a crucial role in obtaining accurate and reliable measurements. The growing number of applications for intracranial pressure monitoring, including traumatic brain injuries, hydrocephalus, intracerebral hemorrhage, and brain tumors, has created a demand for specialized electrodes tailored to the specific needs of each condition. Manufacturers are investing in research and development to design electrodes that are easy to implant, provide stable and consistent measurements, and minimize the risk of complications or infections.

Regional Insights

North america: dominant region with 5.2% market share

North America is the most significant global market shareholder and is estimated to grow at a CAGR of 5.2% over the forecast period. The key elements contributing to the market growth in North America include the availability of technologically advanced devices and an increase in the adoption of intracranial pressure monitoring procedures. In addition, growth in the region is also driven by factors such as the increasing number of trauma cases and improved healthcare facilities. Supportive government initiatives, including establishing the American Society of Craniofacial Surgery (ASCFS) to create awareness about minimally invasive Craniomaxillofacial (CMF) surgeries, are forecasted to propel the market expansion during the anticipated period.

Moreover, rising demand for minimally invasive surgeries is further anticipated to contribute to the market's growth over the forecast period. North America's leading position in the global market can be attributed to its advanced healthcare infrastructure, high prevalence of neurological disorders, favorable reimbursement policies, and key market players. With ongoing advancements in technology and increasing demand for accurate intracranial pressure monitoring, the market in North America is expected to continue its growth trajectory over the forecast period.

Europe: fastest growing region with the highest cagr

Europe is anticipated to exhibit a CAGR of 5.1% over the forecast period. Europe's intracranial pressure monitoring devices market is expected to exhibit significant growth over the anticipated period owing to a well-established healthcare system and increasing demand for minimally invasive surgeries. Various factors, like the increasing geriatric population and rapid technological advancements in reconstruction surgery, are expected to propel the market demand. Increasing adoption of technologically advanced devices and a growing number of CMF surgeries are also anticipated to propel market growth. The UK and Germany are the major markets in Europe.

The Asia-Pacific intracranial pressure monitoring devices market is driven by the increasing incidence of sports injuries and trauma. In addition, emerging economies like China, Japan, South Korea, and India are forecasted to witness considerable growth rates over the forecast period. Moreover, several local players in China and Japan may boost the market growth. However, certain developing countries, such as Vietnam, Malaysia, and New Zealand, are forecasted to witness a moderate growth rate over the anticipated period. Low adoption of advanced healthcare facilities and shortage of skilled professionals in these countries may hinder market growth.

The Latin American intracranial pressure monitoring devices market is anticipated to grow significantly during the anticipated period. The presence of developing economies, like Brazil and Mexico, is forecasted to drive the overall Latin American market primarily. The accessibility of affordable, cutting-edge treatment alternatives in Latin America makes the region a preferred destination for medical tourism. Moreover, governments of Latin American countries are consistently involved in improving healthcare infrastructure. Thus, these factors are expected to fuel the growth of the Latin American market over the forecast period.

The Middle East and Africa (MEA) intracranial pressure monitoring devices market is forecasted to grow moderately over the forecast period. Middle Eastern countries such as Saudi Arabia, South Africa, and the United Arab Emirates are prospering economies. Increasing healthcare expenditure and the gradual adoption of technologically advanced products in these countries are expected to boost market growth. In addition, the increasing incidence of traumatic injuries and road accidents in South Africa, Saudi Arabia, and the UAE is expected to propel market growth.

Intracranial Pressure Monitoring Devices Market Segmentation Analysis

By technique

The gmarket is bifurcated into invasive and non-invasive. The invasive segment dominates the global market and is projected to exhibit a CAGR of 5.2% over the forecast period. Invasive techniques are widely used for measuring elevated ICP. Invasive ICP measurement can be performed at various intracranial anatomical locations, i.e., intraventricular, intraparenchymal, epidural, subdural, and subarachnoidal. The two invasive techniques currently being used are external ventricular drain and micro transducer ICP monitoring.

Furthermore, the invasive segment offers a wide range of catheter types and configuration options, allowing healthcare providers to select the most suitable device for each patient's needs. Different catheter designs and materials offer varying levels of invasiveness and can be tailored to the individual patient's condition. This flexibility and customization contribute to the dominance of the invasive segment in the market.

By application

The market is bifurcated into traumatic brain injury, intracerebral hemorrhage, meningitis, subarachnoid hemorrhage, and others. The traumatic brain injury segment dominates the global market share and is projected to exhibit a CAGR of 5.4% over the forecast period. Traumatic head injuries are one of the main reasons people die worldwide. It is a condition in which the brain is hurt by a mechanical force from the outside, which leads to permanent or temporary impairment of cognitive functions. Most people with severe brain injury die from an ICP that is too high. How well the medicine works depends on how well ICP is measured.

The application of ICP monitoring devices is directly proportional to a global increase in the incidence of traumatic brain injury. According to the CDC, traumatic brain injuries have significantly increased in the past few years. The market for traumatic brain injury in ICP monitoring devices captured the largest share in 2019.

By end use

The market is bifurcated into emergency rooms, intensive care units, and operating rooms. The emergency rooms segment dominates the global market and is projected to exhibit a CAGR of 5.4% over the forecast period. The usage of ICP monitors is high in trauma care, which is a part of the emergency room. Traumatic brain injuries need to be addressed in emergency rooms. ICP monitors are predominantly used in the management of traumatic brain injuries. Although the incidence of traumatic brain injuries has significantly increased in the last decade, the mortality rate is decreasing. Increasing advanced and minimally invasive treatment adoption is expected to boost demand for novel ICP monitors.

Recent Developments

• April 2023- Medtronic announced the launch of its new EVD system, the EVD Sentinel. The EVD Sentinel is a wireless ICP monitoring system that allows for continuous ICP monitoring and cerebrospinal fluid drainage.
• March 2023- Integra LifeSciences announced the launch of its new subarachnoid bolt, the Codman MicroSensor ICP Bolt. The Codman MicroSensor ICP Bolt is a small, minimally invasive ICP monitoring device inserted into the subarachnoid space.